Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). PDS Biotechnology's share price for the quarter that ended in Dec. 2023 was $4.97. PDS Biotechnology's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 33.09 Mil. Therefore, PDS Biotechnology's market cap for the quarter that ended in Dec. 2023 was $164.48 Mil.
PDS Biotechnology's quarterly market cap
increased
from Jun. 2023 ($155.27 Mil) to Sep. 2023 ($156.59 Mil) and
increased
from Sep. 2023 ($156.59 Mil) to Dec. 2023 ($164.48 Mil).
PDS Biotechnology's annual market cap
increased
from Dec. 2021 ($230.43 Mil) to Dec. 2022 ($398.25 Mil) but then
declined
from Dec. 2022 ($398.25 Mil) to Dec. 2023 ($164.48 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PDS Biotechnology's Enterprise Value for Today is $90.17 Mil.
PDS Biotechnology Market Cap Historical Data
The historical data trend for PDS Biotechnology's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of PDS Biotechnology's Market Cap
For the Biotechnology subindustry, PDS Biotechnology's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PDS Biotechnology's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PDS Biotechnology's Market Cap distribution charts can be found below:
* The bar in red indicates where PDS Biotechnology's Market Cap falls into.
PDS Biotechnology Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
PDS Biotechnology's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PDS Biotechnology (NAS:PDSB) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
PDS Biotechnology Market Cap Related Terms
Thank you for viewing the detailed overview of PDS Biotechnology's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
PDS Biotechnology (PDS Biotechnology) Business Description
PDS Biotechnology Corp operates as a clinical-stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PDSB has been successfully added to your 